These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 30196334)

  • 1. Abdominal obesity, glucose intolerance and decreased high-density lipoprotein cholesterol as components of the metabolic syndrome are associated with the development of colorectal cancer.
    Choi YJ; Lee DH; Han KD; Shin CM; Kim N
    Eur J Epidemiol; 2018 Nov; 33(11):1077-1085. PubMed ID: 30196334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population.
    Liu CS; Hsu HS; Li CI; Jan CI; Li TC; Lin WY; Lin T; Chen YC; Lee CC; Lin CC
    BMC Gastroenterol; 2010 May; 10():51. PubMed ID: 20507579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship Between Two Common Lipoprotein Lipase Variants and the Metabolic Syndrome and Its Individual Components.
    Vishram JK; Hansen TW; Torp-Pedersen C; Madsbad S; Jørgensen T; Fenger M; Lyngbæk S; Jeppesen J
    Metab Syndr Relat Disord; 2016 Nov; 14(9):442-448. PubMed ID: 27676127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Association Between Metabolic Syndrome and Colorectal Cancer Risk by Obesity Status in Korean Women: A Nationwide Cohort Study.
    Moon SG; Park B
    J Prev Med Public Health; 2022 Sep; 55(5):475-484. PubMed ID: 36229910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between metabolic syndrome and its components and incident colorectal cancer in a prospective cohort study.
    Tran TT; Gunathilake M; Lee J; Kim J
    Cancer; 2022 Mar; 128(6):1230-1241. PubMed ID: 34762301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome and its component traits present gender-specific association with liver cancer risk: a prospective cohort study.
    Xia B; Peng J; Enrico T; Lu K; Cheung EC; Kuo Z; He Q; Tang Y; Liu A; Fan D; Zhang C; He Y; Pan Y; Yuan J
    BMC Cancer; 2021 Oct; 21(1):1084. PubMed ID: 34620113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome and risk of Parkinson disease: A nationwide cohort study.
    Nam GE; Kim SM; Han K; Kim NH; Chung HS; Kim JW; Han B; Cho SJ; Yu JH; Park YG; Choi KM
    PLoS Med; 2018 Aug; 15(8):e1002640. PubMed ID: 30130376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic Syndrome and the Risk of Thyroid Cancer: A Nationwide Population-Based Cohort Study.
    Park JH; Choi M; Kim JH; Kim J; Han K; Kim B; Kim DH; Park YG
    Thyroid; 2020 Oct; 30(10):1496-1504. PubMed ID: 32524894
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk of metabolic syndrome in postmenopausal breast cancer survivors.
    Buttros Dde A; Nahas EA; Vespoli Hde L; Uemura G; de Almeida Bda R; Nahas-Neto J
    Menopause; 2013 Apr; 20(4):448-54. PubMed ID: 23149866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic predispositions and increased risk of colorectal adenocarcinoma by anatomical location: a large population-based cohort study in Norway.
    Lu Y; Ness-Jensen E; Hveem K; Martling A
    Am J Epidemiol; 2015 Nov; 182(10):883-93. PubMed ID: 26511906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome and risks of colon and rectal cancer: the European prospective investigation into cancer and nutrition study.
    Aleksandrova K; Boeing H; Jenab M; Bas Bueno-de-Mesquita H; Jansen E; van Duijnhoven FJ; Fedirko V; Rinaldi S; Romieu I; Riboli E; Romaguera D; Overvad K; Østergaard JN; Olsen A; Tjønneland A; Boutron-Ruault MC; Clavel-Chapelon F; Morois S; Masala G; Agnoli C; Panico S; Tumino R; Vineis P; Kaaks R; Lukanova A; Trichopoulou A; Naska A; Bamia C; Peeters PH; Rodríguez L; Buckland G; Sánchez MJ; Dorronsoro M; Huerta JM; Barricarte A; Hallmans G; Palmqvist R; Khaw KT; Wareham N; Allen NE; Tsilidis KK; Pischon T
    Cancer Prev Res (Phila); 2011 Nov; 4(11):1873-83. PubMed ID: 21697276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated Neutrophil-to-Lymphocyte Ratio in Metabolic Syndrome Is Associated with Increased Risk of Colorectal Adenoma.
    Kim JH; Cho KI; Kim YA; Park SJ
    Metab Syndr Relat Disord; 2017 Oct; 15(8):393-399. PubMed ID: 28910195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome and its associated risk factors in Brazilian postmenopausal women.
    Petri Nahas EA; Padoani NP; Nahas-Neto J; Orsatti FL; Tardivo AP; Dias R
    Climacteric; 2009 Oct; 12(5):431-8. PubMed ID: 19415539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between metabolic syndrome and the incidence of colorectal cancer.
    Lee J; Lee KS; Kim H; Jeong H; Choi MJ; Yoo HW; Han TH; Lee H
    Environ Health Prev Med; 2020 Feb; 25(1):6. PubMed ID: 32075578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome, its components, and gastrointestinal cancer risk: a meta-analysis of 31 prospective cohorts and Mendelian randomization study.
    Zhan ZQ; Chen YZ; Huang ZM; Luo YH; Zeng JJ; Wang Y; Tan J; Chen YX; Fang JY
    J Gastroenterol Hepatol; 2024 Apr; 39(4):630-641. PubMed ID: 38230882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity-related parameters and colorectal adenoma development.
    Kim TJ; Kim JE; Choi YH; Hong SN; Kim YH; Chang DK; Rhee PL; Kim MJ; Jung SH; Son HJ
    J Gastroenterol; 2017 Dec; 52(12):1221-1229. PubMed ID: 28197803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Metabolic Syndrome and the Risk of Colorectal Cancer Diagnosed Before Age 50 Years According to Tumor Location.
    Jin EH; Han K; Lee DH; Shin CM; Lim JH; Choi YJ; Yoon K
    Gastroenterology; 2022 Sep; 163(3):637-648.e2. PubMed ID: 35643169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Egg Consumption and Risk of Metabolic Syndrome in Korean Adults: Results from the Health Examinees Study.
    Shin S; Lee HW; Kim CE; Lim J; Lee JK; Lee SA; Kang D
    Nutrients; 2017 Jul; 9(7):. PubMed ID: 28671590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome and low high-density lipoprotein cholesterol are associated with adverse pathological features in patients with prostate cancer treated by radical prostatectomy.
    Lebdai S; Mathieu R; Leger J; Haillot O; Vincendeau S; Rioux-Leclercq N; Fournier G; Perrouin-Verbe MA; Doucet L; Azzouzi AR; Rigaud J; Renaudin K; Charles T; Bruyere F; Fromont G
    Urol Oncol; 2018 Feb; 36(2):80.e17-80.e24. PubMed ID: 29153942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of colorectal adenoma with components of metabolic syndrome.
    Kim BC; Shin A; Hong CW; Sohn DK; Han KS; Ryu KH; Park BJ; Nam JH; Park JW; Chang HJ; Choi HS; Kim J; Oh JH
    Cancer Causes Control; 2012 May; 23(5):727-35. PubMed ID: 22450737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.